Detailed Quote
5i Report
Rating
B+
Review of Lumine Group Inc.
JUL 16, 2024 - The story of LMN as an “early CSU” remains largely intact. There is room for improvement in terms of organic growth. CSU’s group of companies have mostly been very conservative when it comes to debt financing. We think putting slightly more debt on the balance sheet to do more acquisitions totally makes sense given the recurring revenue business model. We think LMN’s story remains intact, and we expect the company can continue to compound free cash flow per share at a decent rate going forward - we are maintaining our rating at B+.
Download ReportCompany Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: I have a partial position in Constellation and Lumine and would like to top one up...which is better at this moment...long term investor....thanks for all that you do. Geoff
-
Constellation Software Inc. (CSU)
-
Knight Therapeutics Inc. (GUD)
-
Topicus.com Inc. (TOI)
-
Lumine Group Inc. (LMN)
Q: HI,
I dont have any credits and if you can assist in answering the question would appreciate it. Is CSU, LMN, and TOI still buys at today's prices . At this point, Is Knight worth holding? Thanks for your service
I dont have any credits and if you can assist in answering the question would appreciate it. Is CSU, LMN, and TOI still buys at today's prices . At this point, Is Knight worth holding? Thanks for your service
-
Exchange Income Corporation (EIF)
-
WELL Health Technologies Corp. (WELL)
-
Galaxy Digital Inc. Class A common stock (GLXY)
-
Lumine Group Inc. (LMN)
Q: These 4 stocks , held in roughly equal amounts, constitute my TFSA , which holds my riskier , growthier companies. It’s early yet but could you give me 3 companies to review and follow before the next TFSA contribution.
Also, your choice of either PXT or TSU as potential picks. Thanks Derek
Also, your choice of either PXT or TSU as potential picks. Thanks Derek
Insiders
Share Information
News and Media